Protocol for eVLP-mediated CRISPR-Cas9 and prime editing in pancreatic cancer cell lines.
A protocol for delivering CRISPR-Cas9 or prime editors into PDAC cell lines using retrovirus-derived engineered virus-like particles (eVLPs) and adapts readily to other genomic sites.